Lauren S. Aaronson Clinical and Translational Science Pilot Program supports investigators’ collaborative pilot research to overcome shared translational barriers and build data for future external funding.
The program is not currently accepting applications; the funder replaced the full request-for-applications link with this notice.
Funder: Frontiers Clinical & Translational Science Institute
Due Dates: October 30, 2026, 11:59 p.m. CT (Letter of intent) | March 3, 2027, 11:59 p.m. CT (Invited full application)
Funding Amounts: Four awards of up to $50,000 each for one year, July 1, 2027–June 30, 2028
Summary: Supports multidisciplinary pilot projects developing generalizable solutions to translational research barriers and preliminary data for future external funding.
Key Information: Requires Frontiers membership, an eligible institutional affiliation, and institutional commitment of 20% total PI effort.
Frontiers Clinical & Translational Science Institute supports investigator-initiated clinical and translational science projects through research funding, proposal review, educational opportunities, and application-development and implementation support. The program emphasizes early- and mid-career investigators undertaking collaborative, one-year projects that generate preliminary data for subsequent externally funded research.
Projects must identify translational barriers and develop solutions applicable across multiple research projects, rather than advance only a particular disease or target. Supported activities include new methods, technologies, tools and resources; early-stage therapies or technologies addressing generalizable barriers; demonstrations of improved translational efficiency; dissemination; and feasibility studies. Programmatic priorities include multidisciplinary perspectives, local and rural health, community-based research, and implementation of clinical findings into practice. Proposals may combine translational research and translational science.